Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Anemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01849237
What this trial is testing

Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe Neutropenia

Who this might be right for
Septic ShockNonchemotherapy Drug-induced NeutropeniaNeutropenia After Chemotherapy in Oncohematological Patients+1 more
National Research Center for Hematology, Russia 30
Not applicableStudy completedNCT02140736
What this trial is testing

Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology

Who this might be right for
Chemotherapy-induced Symptomatic AnemiaSolid TumorsMalignant Hemopathies+2 more
Hospira, now a wholly owned subsidiary of Pfizer 2,333
Testing effectiveness (Phase 2)Study completedNCT05963334
What this trial is testing

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Who this might be right for
Advanced Epithelial Ovarian Cancer
Cairo University 49
Early research (Phase 1)Study completedNCT01213979
What this trial is testing

Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered by 500 mg IV Bolus Injection or 1000 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

Who this might be right for
Non-hematological Malignancies
Pharmacosmos A/S 16
Testing effectiveness (Phase 2)Ended earlyNCT00306267
What this trial is testing

PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy

Who this might be right for
AnemiaCancerEpoetin Alfa
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 61
Large-scale testing (Phase 3)UnknownNCT00482716
What this trial is testing

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+2 more
St. Bartholomew's Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01297543
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+1 more
Cellerant Therapeutics 45
Testing effectiveness (Phase 2)Ended earlyNCT00931606
What this trial is testing

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

Who this might be right for
Chemotherapy Induced Anemia
Merck Sharp & Dohme LLC 30
Large-scale testing (Phase 3)Ended earlyNCT00210730
What this trial is testing

The Duration Study

Who this might be right for
Anemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2
Not applicableStudy completedNCT01933035
What this trial is testing

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

Who this might be right for
Immune ThrombocytopeniaChemotherapy Induced ThrombocytopeniaMyelodysplasia+1 more
Beth Israel Medical Center 50
Not applicableStudy completedNCT07790692
What this trial is testing

Efficacy and Safety of Heated Chinese Herb Medicine Patch Therapy on Chemotherapy-Induced Aplastic Anemia

Who this might be right for
CancerAnemia
Hung-Rong Yen 40
Not applicableStudy completedNCT01807091
What this trial is testing

Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid LeukemiaAdult Myelodysplastic Syndrome
University of Washington 17
Testing effectiveness (Phase 2)WithdrawnNCT00481624
What this trial is testing

Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia

Who this might be right for
Anemia
University of Louisville
Large-scale testing (Phase 3)Ended earlyNCT04607668
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):

Who this might be right for
Colorectal Cancer MetastaticMyelosuppression-AdultChemotherapeutic Toxicity
G1 Therapeutics, Inc. 326
Post-approval studies (Phase 4)Study completedNCT01374373
What this trial is testing

Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia

Who this might be right for
Antineoplastic Chemotherapy Induced Anemia
Bio Sidus SA 30
Testing effectiveness (Phase 2)WithdrawnNCT00003407
What this trial is testing

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaMyelodysplastic Syndromes+1 more
Rush University Medical Center
Testing effectiveness (Phase 2)Study completedNCT04076943
What this trial is testing

Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia

Who this might be right for
Chemotherapy Induced Anemia
Kyntra Bio 92
Testing effectiveness (Phase 2)Looking for participantsNCT07663864
What this trial is testing

Luspatercept for CIA in AML

Who this might be right for
Chemotherapy-inducing Anemia
Guangdong Second Provincial General Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00272662
What this trial is testing

Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy

Who this might be right for
Chemotherapy Induced AnemiaCancer
Affymax 60
Large-scale testing (Phase 3)Study completedNCT01145638
What this trial is testing

Intravenous Iron Isomaltoside 1000 (Monofer®) as Mono Therapy (Without Erythropoiesis Stimulating Agents) in Comparison With Oral Iron Sulfate in Subjects With Non-myeloid Malignancies Associated With Chemotherapy Induced Anaemia (CIA)

Who this might be right for
Non-myeloid MalignanciesChemotherapy Induced Anaemia
Pharmacosmos A/S 350
Next Page